Patient-Derived Xenografts for Various Cancers
Patient-Derived Xenografts to Reduce Cancer Health Disparities
- Age
- 21 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- University of California, Davis · Other
This trial is looking for patients with bladder, lung, gastric, or liver cancer. Participants will help researchers understand treatment differences among racial and ethnic groups.
You may be able to join if
- I am receiving treatment for bladder cancer
- I am receiving treatment for lung cancer
- I am receiving treatment for gastric cancer
- I am receiving treatment for liver cancer
- I have signed an informed consent
You may not be able to join if
- I have not provided informed consent
- I have an unacceptable or degraded specimen
- I am not an adult
- I am pregnant
- I am a prisoner
- I am unable to consent
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.
Loading trial locations…